Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Vanda Pharmaceuticals (VNDA)

Vanda Pharmaceuticals (VNDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Vanda Pharmaceuticals Announces Participation in the J.P. Morgan Healthcare Conference PR Newswire - Thu Dec 11, 4:02PM CST

WASHINGTON , Dec. 11, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the company will participate in the J.P. Morgan Healthcare Conference in San Francisco,...

VNDA : 6.23 (-5.61%)
FDA Lifts Partial Clinical Hold on Tradipitant for Motion Sickness PR Newswire - Thu Dec 4, 3:21PM CST

WASHINGTON , Dec. 4, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) has lifted the partial clinical hold on protocol...

VNDA : 6.23 (-5.61%)
Vanda Pharmaceuticals Provides Regulatory Update on Tradipitant for Motion Sickness PR Newswire - Fri Nov 28, 6:00AM CST

WASHINGTON , Nov. 28, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA), today announced the following updates regarding tradipitant for motion sickness:

VNDA : 6.23 (-5.61%)
Vanda Pharmaceuticals Reports Positive Results for Tradipitant in Preventing GLP-1 Induced Nausea and Vomiting PR Newswire - Mon Nov 17, 5:37PM CST

Vanda's Tradipitant Study Success Positions it as Key Adjunct in $50B+ Global GLP-1 Agonist Market

VNDA : 6.23 (-5.61%)
Vanda Pharmaceuticals Announces Participation in the Stifel 2025 Healthcare Conference PR Newswire - Wed Nov 5, 4:00PM CST

WASHINGTON , Nov. 5, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA ) today announced that the company will participate in the Stifel 2025 Healthcare Conference in New...

VNDA : 6.23 (-5.61%)
Vanda: Q3 Earnings Snapshot AP - Wed Oct 29, 3:18PM CDT

Vanda: Q3 Earnings Snapshot

VNDA : 6.23 (-5.61%)
Vanda Pharmaceuticals Reports Third Quarter 2025 Financial Results PR Newswire - Wed Oct 29, 3:01PM CDT

WASHINGTON , Oct. 29, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced financial and operational results for the third quarter ended September 30, 2025.

VNDA : 6.23 (-5.61%)
Vanda Pharmaceuticals to Announce Third Quarter 2025 Financial Results on October 29, 2025 PR Newswire - Wed Oct 22, 3:30PM CDT

Conference Call and Webcast to Follow

VNDA : 6.23 (-5.61%)
Monumental Sports & Entertainment Taps D.C.'s Own Vanda Pharmaceuticals as Founding Partner to Help Drive the Creation of Brand-New Downtown Arena PR Newswire - Wed Oct 8, 7:00AM CDT

Multiyear agreement includes exclusive Monumental Sports Network studio entitlement, activations across Capitals, Wizards, and Mystics, and deep integration via community and media platforms

VNDA : 6.23 (-5.61%)
Vanda Pharmaceuticals Reaches Agreement with FDA Tipranks - Thu Oct 2, 4:30PM CDT

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Vanda ( (VNDA)...

VNDA : 6.23 (-5.61%)

Barchart Exclusives

Inflation Data, AI Earnings and Other Can't Miss Items this Week Barchart - Sun Dec 14, 12:00PM CST
Markets enter a critical week still reeling from Friday's sharp selloff in technology and AI stocks following disappointing reactions to Oracle and Broadcom earnings that raised questions about AI infrastructure spending sustainability and return on massive capital investments. Here are 5 things to watch this week in the Market. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot